Applonia Rose: Advancing cancer treatment with Hadron Therapy
Applonia Rose, Managing Editor at Sage Publishing, shared a post on LinkedIn about a recent paper by Manjit Dosanjh et al. published in TCRT:
“Advancing Cancer Treatment with Hadron Therapy: New review published in Technology in Cancer Research and Treatment (TCRT).
Seventy years ago, the first patient was treated with protons at Berkeley Lab and the same year CERN (European Organization for Nuclear Research) was founded. This milestone inspired the authors of our latest review, whose roots are deeply embedded in CERN’s legacy of particle therapy, accelerator technology, and global collaboration.
Hadron Therapy (HT) continues to push the boundaries of cancer treatment, offering unparalleled precision while preserving healthy tissue. However, translating advanced accelerator technologies into widespread clinical practice remains a challenge. This paper highlights the critical role of multidisciplinary collaboration and showcases three cutting-edge developments that could shape the future of HT.
From Boron Neutron Capture Therapy (BNCT) to image-guided hadron beams and FLASH therapy, continuous innovation is key to making HT more accessible and affordable for patients worldwide.
Having worked closely with Dr. Manjit Dosanjh on this paper, it’s always inspiring to see how multidisciplinary collaboration drives innovation in cancer treatment.”
“Multidisciplinary Collaboration and Novel Technological Advances in Hadron Therapy”
Authors: Manjit Dosanjh, Alberto Degiovanni, Maria Monica Necchi, Elena Benedetto.
More posts featuring Applonia Rose.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023